Phase 3 biotech developing immunotherapies for breast cancer.
Industry: Health Care
First Day Return: -13.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/01/2020 |
Offer Price | $5.75 |
Price Range $5.75 - $6.75 | |
Offer Shares (mm) | 1.3 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/24/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Stafford, TX, United States |
Founded | 2006 |
Employees at IPO | 3 |
Website www.greenwichlifesciences.com |